Company Overview of Cognosci Inc.
Cognosci Inc. engages in discovering and developing anti-inflammatory compounds for the treatment of neuroinflammatory diseases. Its products include COG112 to treat multiple sclerosis; and COG1410 to treat traumatic brain injuries and Alzheimer’s disease. The company also offers products to treat ischemic stroke/subarachnoid hemorrhage, spinal cord injury, Parkinson's disease, rheumatoid arthritis, and sepsis. Cognosci was founded in 2000 and is based in Research Triangle Park, North Carolina.
79 T. W. Alexander Drive
4401 Research Commons
Research Triangle Park, NC 27709
Founded in 2000
Key Executives for Cognosci Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Cognosci Inc., please visit www.cognosci.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.